Topics

Transgene and AstraZeneca Enter Collaboration and Exclusive License Agreement for Innovative Invir.IO Based Armed Oncolytic Immunotherapies

15:19 EDT 2 May 2019 | Speciality Pharma Journal

STRASBOURG, France–(BUSINESS WIRE)–Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies against cancers and infectious diseases announces the signing of a collaborative research, option and exclusive license agreement with AstraZeneca to co-develop five armed oncolytic vaccinia virus candidates. Innovative oncolytic viruses resulting from this collaboration will use Transgene’s proprietary …

Original Article: Transgene and AstraZeneca Enter Collaboration and Exclusive License Agreement for Innovative Invir.IO Based Armed Oncolytic Immunotherapies

NEXT ARTICLE

More From BioPortfolio on "Transgene and AstraZeneca Enter Collaboration and Exclusive License Agreement for Innovative Invir.IO Based Armed Oncolytic Immunotherapies"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...